Official: Uthever® NMN Secures FDA NDI Clearance

Overview

Effepharm

Why choose Uthever®?

Stronger compliance: Uthever® has secured an FDA NDI notification (NDI 1267), confirming the compliance of its NMN ingredient.

Greater market recognition: Uthever® is widely trusted by brands and has been recognized as the *No.1 trademarked NMN ingredient brand in the U.S.

Clinically validated efficacy: Uthever® NMN completed the first large-scale human clinical study, providing scientific evidence for safety and efficacy.

What is the FDA-recognized recommended NMN dosage? What do our human clinical trial data reveal?

Download our latest NMN whitepaper to find out more.

This content is paid by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now

Related Topics

Health

Latest Content

Related Resources

The Global Regulatory Advantage Behind UTHEVER® NMN

The Global Regulatory Advantage Behind UTHEVER® NMN

Paid for by Effepharm Ltd

White Paper

Regulatory uncertainty remains one of the biggest challenges for NMN brands. Choosing the wrong ingredient could lead to compliance risks & market restrictions.

Discover UTHEVER® NMN’s Global Regulatory Landscape

Discover UTHEVER® NMN’s Global Regulatory Landscape

Paid for by Effepharm Ltd

White Paper

NMN has long faced regulatory challenges. Today, that landscape is changing. We consistently invest in scientific research & quality development, aiming to establish UTHEVER® as the world’s most compliant NMN ingredient brand.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.